Literature DB >> 28787274

Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.

Christiaan F Mooij1, Antonius E van Herwaarden1, Fred C G J Sweep1, Nel Roeleveld1, Chris L de Korte1, Livia Kapusta1, Hedi L Claahsen-van der Grinten1.   

Abstract

BACKGROUND: The aim of the study was to evaluate the cardiovascular and metabolic risk profile in pediatric patients with congenital adrenal hyperplasia (CAH).
METHODS: A cross-sectional study was performed in 27 CAH patients (8-16 years). Blood samples were taken to evaluate circulating cardiovascular risk (CVR) markers. Insulin resistance (IR) was evaluated by homeostatic model assessment (HOMA)-IR. Blood pressure (BP) was evaluated by office BP measurements and 24-h ambulatory BP measurements (24-h ABPM). Dual energy X-ray absorptiometry (DXA) scans were performed in patients >12 years.
RESULTS: Body mass index (BMI) standard deviation score (SDS) was elevated (0.67), with seven patients being overweight and four obese. DXA scans showed percentage body fat SDS of 1.59. Office BP levels were higher than reference values. Twenty-four hour ABPM showed systolic hypertension (n=5), while 11 patients had a non-dipping BP profile. HOMA-IR was >75th percentile in 12 patients.
CONCLUSIONS: CAH patients develop an unfavorable CVR profile already in childhood with increased BMI, increased fat mass, elevated BP levels, a non-dipping BP profile and IR compared to population reference values.

Entities:  

Keywords:  cardiovascular risk; congenital adrenal hyperplasia; hypertension; insulin resistance; obesity

Mesh:

Year:  2017        PMID: 28787274     DOI: 10.1515/jpem-2017-0068

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  6 in total

1.  Cardiovascular Risk Factors in Children and Adolescents with Congenital Adrenal Hyperplasia.

Authors:  Elham Hashemi Dehkordi; Sara Khaheshi; Neda Mostofizadeh; Mahin Hashemipour
Journal:  Adv Biomed Res       Date:  2021-07-29

2.  A rare case report about a congenital adrenal hyperplasia by 21-hydroxylase lock in its pure virilizing form discovered in adolescence.

Authors:  Achwak Alla; Najat Draoui; Imane Rami; Siham Rouf; Hanane Saadi; Imane Kamaoui; Hanane Latrech
Journal:  Ann Med Surg (Lond)       Date:  2022-04-28

3.  The Application of Principal Component Analysis on Clinical and Biochemical Parameters Exemplified in Children With Congenital Adrenal Hyperplasia.

Authors:  Marie Lindhardt Ljubicic; Andre Madsen; Anders Juul; Kristian Almstrup; Trine Holm Johannsen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-31       Impact factor: 5.555

4.  Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents With 21-Hydroxylase Deficiency.

Authors:  Mariska A M Schröder; Antonius E van Herwaarden; Paul N Span; Erica L T van den Akker; Gianni Bocca; Sabine E Hannema; Hetty J van der Kamp; Sandra W K de Kort; Christiaan F Mooij; Dina A Schott; Saartje Straetemans; Vera van Tellingen; Janiëlle A van der Velden; Fred C G J Sweep; Hedi L Claahsen-van der Grinten
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

Review 5.  Components of Metabolic Syndrome in Youth With Classical Congenital Adrenal Hyperplasia.

Authors:  Mimi S Kim; Nicole R Fraga; Nare Minaeian; Mitchell E Geffner
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-24       Impact factor: 5.555

Review 6.  Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia.

Authors:  Mattia Barbot; Pierluigi Mazzeo; Martina Lazzara; Filippo Ceccato; Carla Scaroni
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-01       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.